Kazmierski et al. recently reported that elevated blood tight junction proteins (occludin, claudin-5 or the ratio of claudin-5/zonula occludens-1) correlate to increased incidence of clinical deterioration caused by hemorrhagic transformation in stroke patients who are not treated by tPA17. The gene discussed is CLDN5; the disease is Stroke.